THE USE OF CANNABIDIOL IN THE TREATMENT OF AUTISM SPECTRUM DISORDER

Authors

  • Ingrid Souza dos Santos UNIFACS
  • Taíssa de Cerqueira Alves UNIFACS
  • Cristiane Metzker Santana de Oliveira UFBA

DOI:

https://doi.org/10.51891/rease.v11i12.22708

Keywords:

Cannabidiol. Endocannabinoid system. Autism Spectrum Disorder (ASD).

Abstract

This study aims to analyze advances in the benefits and safety of cannabidiol (CBD) use between 2019 and 2024 in patients with autism spectrum disorder (ASD), a condition that affects social, behavioral, and sensory functioning. Over the years, scientific studies have explored the involvement of the endocannabinoid system (ECS) in this condition through pathophysiological mechanisms that may be modulated by cannabidiol. This research is designed as a literature review with the objective of assessing the impact of CBD use in individuals with ASD.

Downloads

Download data is not yet available.

Author Biographies

Ingrid Souza dos Santos, UNIFACS

Estudante de Biomedicina pela Universidade Salvador (Unifacs).

Taíssa de Cerqueira Alves, UNIFACS

Estudante de biomedicina pela Universidade Salvador (Unifacs).

Cristiane Metzker Santana de Oliveira, UFBA

Orientadora: Farmacêutica formada pela Universidade Federal da Bahia (UFBA) e mestre em Ciências Farmacêuticas pela Universidade Federal da Bahia (UFBA).

Downloads

Published

2025-12-03

How to Cite

Santos, I. S. dos, Alves, T. de C., & Oliveira, C. M. S. de. (2025). THE USE OF CANNABIDIOL IN THE TREATMENT OF AUTISM SPECTRUM DISORDER. Revista Ibero-Americana De Humanidades, Ciências E Educação, 11(12), 821–830. https://doi.org/10.51891/rease.v11i12.22708

Issue

Vol. 11 No. 12 (2025): Revista Ibero-Americana de Humanidades, Ciências e Educação — REASE

Section

Artigos

Categories

License

Atribuição CC BY